Exact Mass: 324.1759058

Exact Mass Matches: 324.1759058

Found 500 metabolites which its exact mass value is equals to given mass value 324.1759058, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Citalopram

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile

C20H21FN2O (324.1637828)


Citalopram is an antidepressant drug used to treat depression associated with mood disorders. It is also used on occasion in the treatment of body dysmorphic disorder and anxiety; Citalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is sold under the brand-names Celexa (U.S., Forest Laboratories, Inc.), Cipramil, Seropram (Europe and Australia) and Ciazil (Australia); A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition; Citalopram is an antidepressant drug used to treat depression associated with mood disorders. It is also used on occasion in the treatment of body dysmorphic disorder and anxiety. Citalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Citalopram is an antidepressant drug used to treat depression associated with mood disorders. It is also used on occasion in the treatment of body dysmorphic disorder and anxiety; Citalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is sold under the brand-names Celexa (U.S., Forest Laboratories, Inc.), Cipramil, Seropram (Europe and Australia) and Ciazil (Australia); A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition; Citalopram is an antidepressant drug used to treat depression associated with mood disorders. It is also used on occasion in the treatment of body dysmorphic disorder and anxiety. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators

   

Oxyphenbutazone

3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene

C19H20N2O3 (324.147385)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Oxyphenbutazone is a Phenylbutazone (HY-B0230) metabolite, with anti-inflammatory effect. Oxyphenbutazone is an orally active non-selective COX inhibitor. Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis[1][2].

   

Quinine

(R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol

C20H24N2O2 (324.18376839999996)


Quinine is a cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. It has a role as an antimalarial, a muscle relaxant and a non-narcotic analgesic. It is a conjugate base of a quinine(1+). It derives from a hydride of an (8S)-cinchonan. An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Quinine is an Antimalarial. Quinine is a natural cinchona alkaloid that has been used for centuries in the prevention and therapy of malaria. Quinine is also used for idiopathic muscle cramps. Quinine therapy has been associated with rare instances of hypersensitivity reactions which can be accompanied by hepatitis and mild jaundice. Quinine is a natural product found in Cinchona calisaya, Cinchona officinalis, and other organisms with data available. Quinine is a quinidine alkaloid isolated from the bark of the cinchona tree. Quinine has many mechanisms of action, including reduction of oxygen intake and carbohydrate metabolism; disruption of DNA replication and transcription via DNA intercalation; and reduction of the excitability of muscle fibers via alteration of calcium distribution. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04) Quinine is an alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. See also: Quinine Sulfate (active moiety of); Quinine salicylate (active moiety of); Quinine arsenite (active moiety of) ... View More ... Quinine is an alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. [PubChem]. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BC - Methanolquinolines A cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000700 - Analgesics It is used in tonics and bitter drinks [Raw Data] CB141_Quinine_pos_10eV_CB000051.txt [Raw Data] CB141_Quinine_pos_20eV_CB000051.txt [Raw Data] CB141_Quinine_pos_40eV_CB000051.txt [Raw Data] CB141_Quinine_pos_50eV_CB000051.txt [Raw Data] CB141_Quinine_pos_30eV_CB000051.txt Quinine is an alkaloid derived from the bark of the cinchona tree, acts as an anti-malaria agent. Quinine is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2]. Quinine is an alkaloid derived from the bark of the cinchona tree, acts as an anti-malaria agent. Quinine is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].

   

Dolasetron

1H-Indole-3-carboxylic acid, (6R,9as)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel-, methanesulfonate, hydrate (1:1:1)

C19H20N2O3 (324.147385)


Dolasetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Dolasetron is a highly specific and selective serotonin 5-HT3 receptor antagonist. This drug has not shown to have activity at other known serotonin receptors, and has low affinity for dopamine receptors. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

   

Affinine

17-Hydroxyvobasan-3-one

C20H24N2O2 (324.18376839999996)


   

Ambrosanolide

Tetraneurin E; Ambrosanolide

C17H24O6 (324.1572804)


   
   
   

Piperonyl sulfoxide

1,2-(Methylenedioxy)-4-(2-(octylsulfinyl)propyl)benzene

C18H28O3S (324.1759058)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   
   

5-(galactosylhydroxy)-L-lysine

(2S)-6-amino-2-{N-hydroxy[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}hexanoic acid

C12H24N2O8 (324.15325839999997)


Galactosylhydroxylysine is released during bone resorption and elevated in subjects with metabolic bone loss. Galactosylhydroxylysine is a sensitive and specific marker of bone resorption. (PMID 10222355).

   

Quinidine

(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

C20H24N2O2 (324.18376839999996)


Crystals or white powder. (NTP, 1992) Quinidine is a cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. It has a role as an alpha-adrenergic antagonist, an antimalarial, an anti-arrhythmia drug, a sodium channel blocker, a muscarinic antagonist, a potassium channel blocker, a P450 inhibitor, an EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor, an EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor and a drug allergen. It derives from a hydride of a cinchonan. Quinidine is a D-isomer of [quinine] present in the bark of the Cinchona tree and similar plant species. This alkaloid was first described in 1848 and has a long history as an antiarrhythmic medication. Quinidine is considered the first antiarrhythmic drug (class Ia) and is moderately efficacious in the acute conversion of atrial fibrillation to normal sinus rhythm. It prolongs cellular action potential by blocking sodium and potassium currents. A phenomenon known as “quinidine syncope” was first described in the 1950s, characterized by syncopal attacks and ventricular fibrillation in patients treated with this drug. Due to its side effects and increased risk of mortality, the use of quinidine was reduced over the next few decades. However, it continues to be used in the treatment of Brugada syndrome, short QT syndrome and idiopathic ventricular fibrillation. Quinidine is an Antiarrhythmic and Cytochrome P450 2D6 Inhibitor. The mechanism of action of quinidine is as a Cytochrome P450 2D6 Inhibitor. Quinidine is a natural cinchona alkaloid which has potent antiarrhythmic activity and has been used for decades in the treatment of atrial and ventricular arrhythmias. Quinidine has been associated with fever, mild jaundice and clinically apparent liver injury in up to 2\\\\% of treated patients. Quinidex is a natural product found in Cinchona calisaya, Aspidosperma excelsum, and other organisms with data available. Quinidine is an alkaloid extracted from the bark of the Cinchona tree with class 1A antiarrhythmic and antimalarial effects. Quinidine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting the sodium influx required for the initiation and conduction of impulses resulting in an increase of the threshold for excitation and decreased depolarization during phase 0 of the action potential. In addition, the effective refractory period (ERP), action potential duration (APD), and ERP/APD ratios are increased, resulting in decreased conduction velocity of nerve impulses. Quinidine exerts its antimalarial activity by acting primarily as an intra-erythrocytic schizonticide through association with the heme polymer (hemazoin) in the acidic food vacuole of the parasite thereby preventing further polymerization by heme polymerase enzyme. This results in accumulation of toxic heme and death of the parasite. An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. See also: Quinidine Gluconate (active moiety of); Quinidine Sulfate (active moiety of); Quinidine polygalacturonate (is active moiety of). An optical isomer of quinine, extracted from the bark of the Cinchona tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular action potential, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. [PubChem] C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BA - Antiarrhythmics, class ia A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS [Raw Data] CBA33_Quinidine_pos_50eV_1-1_01_1622.txt [Raw Data] CBA33_Quinidine_pos_30eV_1-1_01_1620.txt [Raw Data] CBA33_Quinidine_pos_40eV_1-1_01_1621.txt [Raw Data] CBA33_Quinidine_pos_20eV_1-1_01_1619.txt [Raw Data] CBA33_Quinidine_pos_10eV_1-1_01_1616.txt Quinidine (15\\% dihydroquinidine) is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine is also a K+ channel blocker with an IC50 of 19.9 μM, and can induce apoptosis. Quinidine can be used for malaria research[1][2][3][4]. Quinidine (15\% dihydroquinidine) is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine is also a K+ channel blocker with an IC50 of 19.9 μM, and can induce apoptosis. Quinidine can be used for malaria research[1][2][3][4].

   

2,3-Epoxymenaquinone

1a-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-7a-methyl-1aH,2H,7H,7aH-naphtho[2,3-b]oxirene-2,7-dione

C21H24O3 (324.1725354)


This compound belongs to the family of Vitamin K Compounds. These are quinone lipids containing a methylated naphthoquinone ring structure, and vary in the aliphatic side chain attached at the 3-position.

   

Etonogestrel

Etonogestrel

C22H28O2 (324.2089188)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

dolasetron

dolasetron

C19H20N2O3 (324.147385)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

   

Bindarit

Propanoic acid, 2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3-yl]methoxy]-

C19H20N2O3 (324.147385)


Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C29629 - Combination Medication > C29634 - Antirheumatic Preparation D000893 - Anti-Inflammatory Agents Bindarit (AF2838) is a selective inhibitor of the monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7, and MCP-2/CCL8, and no effect on other CC and CXC chemokines such as MIP-1α/CCL3, MIP-1β/CCL4, MIP-3/CCL23. Bindarit also has anti-inflammatory activity[1].

   

Escitalopram

(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile

C20H21FN2O (324.1637828)


Escitalopram is a furancarbonitrile that is one of the Serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition; Escitalopram (Cipralex) is a medication developed by the Danish pharmaceutical company Lundbeck, that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD. In the United States, the drug is marketed under the name Lexapro by Forest Laboratories, Inc; Escitalopram is a medication that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD; Discontinuation from antidepressants, especially abruptly, has been known to cause certain withdrawal symptoms. One possible discontinuation symptom from Escitalopram is a type of spontaneous nerve pulse known as paresthesia or electric shock sensations, described by some patients as a feeling of small electric shocks, which may be accompanied by dizziness. These pulses may be short in duration, only milliseconds long, may affect any region of the body, and recur up to several times a minute, throughout all waking hours. They can be increased by physical activity, but are not solely linked to muscular activity. Other discontinuation symptoms include extreme sensitivity to loud sounds and bright lights, chills, hot flushes, cold sweats, reddening of the face, abdominal pain, weight gain and extreme mental fatigue. A furancarbonitrile that is one of the Serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition; Escitalopram (Cipralex) is a medication developed by the Danish pharmaceutical company Lundbeck, that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD. In the United States, the drug is marketed under the name Lexapro by Forest Laboratories, Inc; Escitalopram is a medication that acts as a selective serotonin reuptake inhibitor (SSRI). It is typically used as an antidepressant to treat depression associated with mood disorders, although it also may be used in the treatment of body dysmorphic disorder and anxiety, including OCD; Discontinuation from antidepressants, especially abruptly, has been known to cause certain withdrawal symptoms. One possible discontinuation symptom from Escitalopram is a type of spontaneous nerve pulse known as paresthesia or electric shock sensations, described by some patients as a feeling of small electric shocks, which may be accompanied by dizziness. These pulses may be short in duration, only milliseconds long, may affect any region of the body, and recur up to several times a minute, throughout all waking hours. They can be increased by physical activity, but are not solely linked to muscular activity. Other discontinuation symptoms include extreme sensitivity to loud sounds and bright lights, chills, hot flushes, cold sweats, reddening of the face, abdominal pain, weight gain and extreme mental fatigue. [HMDB] N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression[1][2].

   

Valaciclovir

2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate

C13H20N6O4 (324.154596)


Valaciclovir (INN) or valacyclovir (USAN) is an antiviral drug used in the management of herpes simplex and herpes zoster (shingles). It is a prodrug, being converted in vivo to aciclovir. It is marketed by GlaxoSmithKline under the trade name Valtrex or Zelitrex. [Wikipedia] J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Monoacetoxyscirpenol

{10,11-dihydroxy-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0²,⁷]dodecan]-5-en-2-yl}methyl acetic acid

C17H24O6 (324.1572804)


Monoacetoxyscirpenol is a mycotoxin from Fusarium roseum and Fusarium sulphureu D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

Blumealactone C

2-Hydroxy-5,9-dimethyl-14-methylidene-13-oxo-4,12-dioxatricyclo[9.3.0.0³,⁵]tetradecan-10-yl acetic acid

C17H24O6 (324.1572804)


Blumealactone C is found in tea. Blumealactone C is a constituent of Blumea balsamifera (sambong) Constituent of Blumea balsamifera (sambong). Blumealactone C is found in tea.

   

4-Acetoxyscirpene-3,15-diol

10-Hydroxy-2-(hydroxymethyl)-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0²,⁷]dodecan]-5-en-11-yl acetic acid

C17H24O6 (324.1572804)


4-Acetoxyscirpene-3,15-diol is a mycotoxin from Fusarium roseum and Fusarium sulphureu D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Mycotoxin from Fusarium roseum and Fusarium sulphureum

   

Lactapiperanol D

10-Hydroxy-13-methoxy-3,6,6-trimethyl-12-oxatetracyclo[8.3.0.0¹,³.0⁴,⁸]tridecan-9-yl acetic acid

C18H28O5 (324.1936638)


Lactapiperanol B is found in mushrooms. Lactapiperanol B is a constituent of Lactarius piperatus.

   

AF Toxin II

(2E,4Z,6E)-8-[(2-hydroxy-3-methylpentanoyl)oxy]-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid

C17H24O6 (324.1572804)


AF Toxin II is found in fruits. AF Toxin II is produced by Alternaria alternata on strawberry. Phytotoxin specific to strawberry and pear. Production by Alternaria alternata on strawberry. Phytotoxin specific to strawberry and pear. AF Toxin II is found in pomes and fruits.

   

3-Acetoxyscirpene-4,15-diol

11-Hydroxy-2-(hydroxymethyl)-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0²,⁷]dodecan]-5-en-10-yl acetic acid

C17H24O6 (324.1572804)


3-Acetoxyscirpene-4,15-diol is a metabolite of Fusarium oxysporum. Mycotoxi

   

Cibaric acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


Cibaric acid is found in mushrooms. Cibaric acid is isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Cibaric acid is found in mushrooms.

   

Etonogestrel

(1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C22H28O2 (324.2089188)


Etonogestrel is only found in individuals that have used or taken this drug. It is a molecule used in hormonal contraceptives, most notably the subdermal implant Implanon. [Wikipedia]Etonogestrel binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like etonogestrel will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

(R)-(6-Methoxy-4-quinolyl)-(5-vinylquinuclidin-2-yl)methanol

{5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl}(6-methoxyquinolin-4-yl)methanol

C20H24N2O2 (324.18376839999996)


   

5-(Galactosylhydroxy)-L-Lysine

(2S)-2,6-diamino-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexanoic acid

C12H24N2O8 (324.15325839999997)


   
   

(2S,5R)-2,6-Diamino-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid

(2S,5R)-2,6-Diamino-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid

C12H24N2O8 (324.15325839999997)


Component of collagen

   

4-Butyl-5-hydroxy-2-(4-hydroxyphenyl)-1-phenyl-1H-pyrazol-3(2H)-one

4-butyl-5-hydroxy-1-(4-hydroxyphenyl)-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

C19H20N2O3 (324.147385)


   

(5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-3-yl)methanol

(5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-3-yl)methanol

C20H24N2O2 (324.18376839999996)


   

Bindarit

2-[(1-benzyl-1h-indazol-3-yl)methoxy]-2-methylpropanoic acid

C19H20N2O3 (324.147385)


D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C29629 - Combination Medication > C29634 - Antirheumatic Preparation D000893 - Anti-Inflammatory Agents Bindarit (AF2838) is a selective inhibitor of the monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7, and MCP-2/CCL8, and no effect on other CC and CXC chemokines such as MIP-1α/CCL3, MIP-1β/CCL4, MIP-3/CCL23. Bindarit also has anti-inflammatory activity[1].

   

Ditazole

2-[(4,5-diphenyl-1,3-oxazol-2-yl)-(2-hydroxyethyl)amino]ethanol

C19H20N2O3 (324.147385)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent

   

epsilon-Deoxy-fructosyl-lysine

2,6-diamino-2-[3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]hexanoic acid

C12H24N2O8 (324.15325839999997)


   

Fluoroprobe

4-[(1-phenylpiperidin-4-ylidene)methyl]naphthalene-1-carbonitrile

C23H20N2 (324.16264)


   

galactosyl hydroxylysine

6-amino-5-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}hexanoic acid

C12H24N2O8 (324.15325839999997)


   

1,2-Diphenyl-3,5-dioxo-4-(3-hydroxybutyl)pyrazolidine

4-(3-hydroxybutyl)-1,2-diphenylpyrazolidine-3,5-dione

C19H20N2O3 (324.147385)


   

L-Prolinamide, 5-oxo-L-prolyl-L-norvalyl-

N-[1-(2-carbamoylpyrrolidin-1-yl)-1-oxopentan-2-yl]-5-oxopyrrolidine-2-carboxamide

C15H24N4O4 (324.1797464)


   

Nitracrine

N-[3-(dimethylamino)propyl]-1-nitroacridin-9-amine

C18H20N4O2 (324.158618)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000970 - Antineoplastic Agents

   

Tecastemizole

1-[(4-fluorophenyl)methyl]-N-(piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-imine

C19H21FN4 (324.1750158)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Tecastemizole (Norastemizole), a major metabolite of Astemizole, is a potent and selective H1 receptor antagonist. Tecastemizole shows anti-inflammatory activities[1].

   

p-Hydroxyubenimex

2-{[3-amino-1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-4-methylpentanoate

C16H24N2O5 (324.1685134)


   

D-Valacyclovir

2-[(6-Hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoic acid

C13H20N6O4 (324.154596)


   

O-Galactosyl-5-hydroxylysine

3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl 2,6-diamino-5-hydroxyhexanoic acid

C12H24N2O8 (324.15325839999997)


   

Citalopram

Citalopram

C20H21FN2O (324.1637828)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent EAWAG_UCHEM_ID 2901; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 2901 CONFIDENCE standard compound; INTERNAL_ID 8590 D049990 - Membrane Transport Modulators

   
   
   
   

15-Desacetyltetraneurin C

15-Desacetyltetraneurin C

C17H24O6 (324.1572804)


   

6beta-Hydroxypulchellin 2-O-acetate

6beta-Hydroxypulchellin 2-O-acetate

C17H24O6 (324.1572804)


   
   

CJ 12373

cis-3-Heptyl-3,4-dihydro-1,6,8-trihydroxy-1H-2-benzopyran-7-carboxylic acid

C17H24O6 (324.1572804)


   
   
   

4alpha,10alpha-Hydroxy-8-acetoxy-1alpha,5alpha,11betaH-guaia-2-en-12,6alpha-olide

4alpha,10alpha-Hydroxy-8-acetoxy-1alpha,5alpha,11betaH-guaia-2-en-12,6alpha-olide

C17H24O6 (324.1572804)


   
   

Marrulanic acid

(-)-Marrulanic acid

C18H28O5 (324.1936638)


   
   
   
   
   

(+)-Paramicholide

(+)-Paramicholide

C17H24O6 (324.1572804)


   

Lochnerine

(19E)-10-Methoxysarpagan-17-ol

C20H24N2O2 (324.18376839999996)


   
   
   
   
   

Alstoumerine

Alstoumerine

C20H24N2O2 (324.18376839999996)


A natural product found in Alstonia macrophylla.

   
   

14-Acetoxy-5alpha-hydroperoxy-11alpha,13-dihydroisoalantolactone

14-Acetoxy-5alpha-hydroperoxy-11alpha,13-dihydroisoalantolactone

C17H24O6 (324.1572804)


   

2-[[2-(3,5-dihydroxy-4-isopropyl-phenyl)-2-guanidino-acetyl]amino]acetic acid

2-[[2-(3,5-dihydroxy-4-isopropyl-phenyl)-2-guanidino-acetyl]amino]acetic acid

C14H20N4O5 (324.143363)


   
   
   

Grindelistrictoic acid

Grindelistrictoic acid

C18H28O5 (324.1936638)


   

3alpha-Hydroxy-8alpha-acetoxy-3-desoxo-11beta,13-dihydroparishin A

3alpha-Hydroxy-8alpha-acetoxy-3-desoxo-11beta,13-dihydroparishin A

C17H24O6 (324.1572804)


   
   

Naematolin B

10-(3-Dimethylaminobutyl)-2-ethylphenothiazine

C17H24O6 (324.1572804)


   

strychnilactone

(-)-Strychnilactone

C17H24O6 (324.1572804)


   

(+)-Almuheptolide A

(+)-Almuheptolide A

C17H24O6 (324.1572804)


   

3,5-Dimethoxy-4-hydroxy-4-(3,3-dimethylallyl) stilbene

3,5-Dimethoxy-4-hydroxy-4-(3,3-dimethylallyl) stilbene

C21H24O3 (324.1725354)


   
   
   
   
   
   
   
   
   
   
   

Tubotaiwine

Methyl (14beta)-2,16-didehydrocondyfolan-16-carboxylate

C20H24N2O2 (324.18376839999996)


Annotation level-1

   

Dihydronorpurpeline

N-Demethyldihydropurpeline

C20H24N2O2 (324.18376839999996)


   

4-tert-Butylbenzo-15-crown-5

4-tert-Butylbenzo-15-crown-5

C18H28O5 (324.1936638)


   
   

(1S,5R,6S)-5-Acetoxy-3-(hydroxymethyl)-6-isopropyl-4-oxo-2-cyclohexen-1-yl (2E)-2-methyl-2-butenoate

(1S,5R,6S)-5-Acetoxy-3-(hydroxymethyl)-6-isopropyl-4-oxo-2-cyclohexen-1-yl (2E)-2-methyl-2-butenoate

C17H24O6 (324.1572804)


   

N-(4-cyano-1-phenyl-1H-pyrazol-5-yl)-2-(4-methylpiperazino)acetamide

N-(4-cyano-1-phenyl-1H-pyrazol-5-yl)-2-(4-methylpiperazino)acetamide

C17H20N6O (324.169851)


   
   

1-Methoxy-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran

1-Methoxy-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran

C22H28O2 (324.2089188)


   
   

NPE_325.1547_12.8

NPE_325.1547_12.8

C19H20N2O3 (324.147385)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1101

   

[(1R,5S,6S)-5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] (E)-2-methylbut-2-enoate

[(1R,5S,6S)-5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] (E)-2-methylbut-2-enoate

C17H24O6 (324.1572804)


   
   

NX2 toxin

NX2 toxin

C17H24O6 (324.1572804)


CONFIDENCE extrolite of Fusarium graminearum, NX-chemotype

   
   
   

Gardnerine

Gardnerine

C20H24N2O2 (324.18376839999996)


Annotation level-1

   

3-Tigloyl,7-Ac-(3beta,5alpha)-3,5,7-Trihydroxy-p-menth-1-en-6-one|7-Acetoxy-5alpha-hydroxy-3beta-tigloyloxycarvotacetone

3-Tigloyl,7-Ac-(3beta,5alpha)-3,5,7-Trihydroxy-p-menth-1-en-6-one|7-Acetoxy-5alpha-hydroxy-3beta-tigloyloxycarvotacetone

C17H24O6 (324.1572804)


   

Me glycoside-4-O-alpha-L-Rhamnopyranosyl-L-rhamnose|Me glycoside-4-O-beta-L-Rhamnopyranosyl-L-rhamnose

Me glycoside-4-O-alpha-L-Rhamnopyranosyl-L-rhamnose|Me glycoside-4-O-beta-L-Rhamnopyranosyl-L-rhamnose

C13H24O9 (324.14202539999997)


   

alstonamic acid|Angustilobine B acid

alstonamic acid|Angustilobine B acid

C19H20N2O3 (324.147385)


   

1-O-beta-D-fructofuranosyl-2R,5R-dihydroxymethyl-3R,4R-dihydroxypyrrolidine

1-O-beta-D-fructofuranosyl-2R,5R-dihydroxymethyl-3R,4R-dihydroxypyrrolidine

C12H24N2O8 (324.15325839999997)


   
   

11-[3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

11-[3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

C18H28O5 (324.1936638)


   

8alpha-acetoxy-1beta-hydroxy-4-epi-arbusculin A

8alpha-acetoxy-1beta-hydroxy-4-epi-arbusculin A

C17H24O6 (324.1572804)


   

11alpha-hydroxycinnamosmolide|9alpha,11alpha-dihydroxy,6beta-acetyl-cinnamolide

11alpha-hydroxycinnamosmolide|9alpha,11alpha-dihydroxy,6beta-acetyl-cinnamolide

C17H24O6 (324.1572804)


   
   
   
   

N(1)-demethylalstonal|N(1)-demethylalstonal

N(1)-demethylalstonal|N(1)-demethylalstonal

C19H20N2O3 (324.147385)


   

1,3-dimethoxy-5-[2-[4-(3-methylbut-2-enoxy)phenyl]ethenyl]benzene

1,3-dimethoxy-5-[2-[4-(3-methylbut-2-enoxy)phenyl]ethenyl]benzene

C21H24O3 (324.1725354)


   

N(1)-demethylalstonisine|N(1)-demethylalsonisine

N(1)-demethylalstonisine|N(1)-demethylalsonisine

C19H20N2O3 (324.147385)


   

8alpha,10beta-dihydroxy-11alpha-acetoxyslov-3-enolide

8alpha,10beta-dihydroxy-11alpha-acetoxyslov-3-enolide

C17H24O6 (324.1572804)


   

3??-Acetoxy-4??-hydroxy-11(13)-eudesmen-12-oic acid methyl ester

3??-Acetoxy-4??-hydroxy-11(13)-eudesmen-12-oic acid methyl ester

C18H28O5 (324.1936638)


   

3,7-seco-cura-2(7),19-dien-17-oic acid methyl ester|Desformylstemmadenin|Desformylstemmadenine

3,7-seco-cura-2(7),19-dien-17-oic acid methyl ester|Desformylstemmadenin|Desformylstemmadenine

C20H24N2O2 (324.18376839999996)


   

15-O-acetyl-3-deoxy-11alpha,13-dihydroxy-11,13-dihydroamphoricarpolide

15-O-acetyl-3-deoxy-11alpha,13-dihydroxy-11,13-dihydroamphoricarpolide

C17H24O6 (324.1572804)


   
   

(19S)-17,19-epoxy-1-methyl-(20alphaH)-19,20-dihydro-sarpagan-21alpha-ol|Talpinin|Talpinine

(19S)-17,19-epoxy-1-methyl-(20alphaH)-19,20-dihydro-sarpagan-21alpha-ol|Talpinin|Talpinine

C20H24N2O2 (324.18376839999996)


   

(1S,4S,5S,6S,7S,10R)-1,4-dihydroxy-15-acetoxyeudesm-11(13)-en-6,12-olide

(1S,4S,5S,6S,7S,10R)-1,4-dihydroxy-15-acetoxyeudesm-11(13)-en-6,12-olide

C17H24O6 (324.1572804)


   

4-muurolen-7,15-diol, 15-malonate ester

4-muurolen-7,15-diol, 15-malonate ester

C18H28O5 (324.1936638)


   

1beta,10beta-epoxy-6beta-(2-semialdehyde acetal hydroxymethylacroyloxy)-8beta-ethoxyeremophil-7(11)-en-12,8alpha-olide

1beta,10beta-epoxy-6beta-(2-semialdehyde acetal hydroxymethylacroyloxy)-8beta-ethoxyeremophil-7(11)-en-12,8alpha-olide

C18H28O5 (324.1936638)


   
   
   
   
   

1,2-Dihydro-(Z,Z)-1,15-Diisothiocyanato-1,14-pentadecadiene

1,2-Dihydro-(Z,Z)-1,15-Diisothiocyanato-1,14-pentadecadiene

C17H28N2S2 (324.1693808)


   
   

3-Hydroxy-6-isopropyl-3-methyl-9-(5-oxotetrahydrofuran-2-yl)-4,9-decadienoic acid

3-Hydroxy-6-isopropyl-3-methyl-9-(5-oxotetrahydrofuran-2-yl)-4,9-decadienoic acid

C18H28O5 (324.1936638)


   

benzoylfervanol|fervanol benzoate

benzoylfervanol|fervanol benzoate

C22H28O2 (324.2089188)


   
   
   
   

Picene, 1,2,3,4-tetrahydro-2,2,9-trimethyl-

Picene, 1,2,3,4-tetrahydro-2,2,9-trimethyl-

C25H24 (324.1877904)


   

2-prenyl-3-hydroxy-5,4-dimethoxystilbene|3-hydroxy-5,4-dimethoxy-2-prenylstilbene|4,5-Di-Me ether-3,4,5-Trihydroxy-2-prenylstilbene

2-prenyl-3-hydroxy-5,4-dimethoxystilbene|3-hydroxy-5,4-dimethoxy-2-prenylstilbene|4,5-Di-Me ether-3,4,5-Trihydroxy-2-prenylstilbene

C21H24O3 (324.1725354)


   

(4-nonylphenyl)benzoate

(4-nonylphenyl)benzoate

C22H28O2 (324.2089188)


   

6-Methyl-2-oxo-tetrahydro-pyran-3-carbonsaeure-(N,N-diphenyl-hydrazid)|6-methyl-2-oxo-tetrahydro-pyran-3-carboxylic acid-(N,N-diphenyl-hydrazide)

6-Methyl-2-oxo-tetrahydro-pyran-3-carbonsaeure-(N,N-diphenyl-hydrazid)|6-methyl-2-oxo-tetrahydro-pyran-3-carboxylic acid-(N,N-diphenyl-hydrazide)

C19H20N2O3 (324.147385)


   

Dimethyl shelloate

Dimethyl shelloate

C17H24O6 (324.1572804)


   
   

8alpha-benzoyloxycaryophyllene

8alpha-benzoyloxycaryophyllene

C22H28O2 (324.2089188)


   

5-methyl-6-[10-(12,12-dimethyl-13beta-hydroxy-16-methenylcyclohexyl)methyl]-1,4-naphthalenedione|cordiaquinone M

5-methyl-6-[10-(12,12-dimethyl-13beta-hydroxy-16-methenylcyclohexyl)methyl]-1,4-naphthalenedione|cordiaquinone M

C21H24O3 (324.1725354)


   

khusol benzoate|Khusolbenzoat

khusol benzoate|Khusolbenzoat

C22H28O2 (324.2089188)


   

4-[2-(3,5-dimethoxyphenyl)ethenyl]-2-(3-methylbut-2-enyl)phenol

4-[2-(3,5-dimethoxyphenyl)ethenyl]-2-(3-methylbut-2-enyl)phenol

C21H24O3 (324.1725354)


   
   

3-Ethyl-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9,10,11-trione

3-Ethyl-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9,10,11-trione

C19H20N2O3 (324.147385)


   

3-Keto-9beta-acetoxyilicic acid

3-Keto-9beta-acetoxyilicic acid

C17H24O6 (324.1572804)


   

2-[(1E,3E)-5-hydroxyhexa-1,3-dien-1-yl]-5-methoxy-4-(3-methoxy-1oxobutyl)-2-methylfuran-3(2H)-one|huaspenone A

2-[(1E,3E)-5-hydroxyhexa-1,3-dien-1-yl]-5-methoxy-4-(3-methoxy-1oxobutyl)-2-methylfuran-3(2H)-one|huaspenone A

C17H24O6 (324.1572804)


   
   
   
   

3beta-acetoxy-1beta,10alpha-epoxy-15-hydroxygermacra-4Z-en-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide C

3beta-acetoxy-1beta,10alpha-epoxy-15-hydroxygermacra-4Z-en-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide C

C17H24O6 (324.1572804)


   

3beta-acetoxy-1alpha,15-dihydroxygermacra-4Z,9Z-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide A

3beta-acetoxy-1alpha,15-dihydroxygermacra-4Z,9Z-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide A

C17H24O6 (324.1572804)


   

15-acetoxy-1beta,3beta-dihydroxygermacra-4Z,10(14)-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide E

15-acetoxy-1beta,3beta-dihydroxygermacra-4Z,10(14)-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide E

C17H24O6 (324.1572804)


   

3beta-acetoxy-1beta,15-dihydroxygermacra-4Z,10(14)-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide F

3beta-acetoxy-1beta,15-dihydroxygermacra-4Z,10(14)-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide F

C17H24O6 (324.1572804)


   

10-oxo-10-(2,3,5-trihydroxy-4-methylphenyl)decanoic acid

10-oxo-10-(2,3,5-trihydroxy-4-methylphenyl)decanoic acid

C17H24O6 (324.1572804)


   

5-Ethyl-7,12-ethano-6,5-(iminopropano)-6-hydroxy-2,3,4,5,6,7-hexahydro-1H-1-benzoazonine-13,17(7)-diene-2,16-dione

5-Ethyl-7,12-ethano-6,5-(iminopropano)-6-hydroxy-2,3,4,5,6,7-hexahydro-1H-1-benzoazonine-13,17(7)-diene-2,16-dione

C19H20N2O3 (324.147385)


   

3alpha-acetoxy-1alpha,8beta-dihydroxyeudesm-7(11)-en-8,12-olide

3alpha-acetoxy-1alpha,8beta-dihydroxyeudesm-7(11)-en-8,12-olide

C17H24O6 (324.1572804)


   
   
   

1-acetyl-condyfol-14(19)-en-11-ol|N-Acetyl-11-hydroxy-aspidospermatidin

1-acetyl-condyfol-14(19)-en-11-ol|N-Acetyl-11-hydroxy-aspidospermatidin

C20H24N2O2 (324.18376839999996)


   
   
   

O-beta-D-Glucopyranoside-16-Ethenyloxayohimban-17-ol

O-beta-D-Glucopyranoside-16-Ethenyloxayohimban-17-ol

C20H24N2O2 (324.18376839999996)


   

(?)-(2R,3R,5S,6S,7R,8S,11S)-8-acetoxy-3,4-dihydroxyguai-11-H-1(10)-en-6,12-olide|argyinolide F

(?)-(2R,3R,5S,6S,7R,8S,11S)-8-acetoxy-3,4-dihydroxyguai-11-H-1(10)-en-6,12-olide|argyinolide F

C17H24O6 (324.1572804)


   

N,N鈥樎?Di-Me,dibenzoyl-1,4-Butanediamine

N,N鈥樎?Di-Me,dibenzoyl-1,4-Butanediamine

C20H24N2O2 (324.18376839999996)


   

12-Methoxy-B(9a)-homo-C-nor-ibogamin-9a-on|12-methoxy-B(9a)-homo-C-nor-ibogamin-9a-one

12-Methoxy-B(9a)-homo-C-nor-ibogamin-9a-on|12-methoxy-B(9a)-homo-C-nor-ibogamin-9a-one

C20H24N2O2 (324.18376839999996)


   

15-Malonyl-4-Amorphene-11,15-diol

15-Malonyl-4-Amorphene-11,15-diol

C18H28O5 (324.1936638)


   
   

2,7-dihydro-1,16-cyclo-coryn-19-en-17-oic acid methyl ester|2,7-Dihydro-pleiocarpamin|2,7-dihydro-pleiocarpamine|pleiocarpamine

2,7-dihydro-1,16-cyclo-coryn-19-en-17-oic acid methyl ester|2,7-Dihydro-pleiocarpamin|2,7-dihydro-pleiocarpamine|pleiocarpamine

C20H24N2O2 (324.18376839999996)


   

11alpha,13-dihydro-2-O-acetylflorilenalin

11alpha,13-dihydro-2-O-acetylflorilenalin

C17H24O6 (324.1572804)


   

(7S,11S)-(+)-12-acetoxysydonic acid|4-[(2S,6S)-7-acetoxy-2-hydroxy-6-methylheptan-2-yl]-3-hydroxybenzoic acid

(7S,11S)-(+)-12-acetoxysydonic acid|4-[(2S,6S)-7-acetoxy-2-hydroxy-6-methylheptan-2-yl]-3-hydroxybenzoic acid

C17H24O6 (324.1572804)


   

3??-Acetoxydiversifolol

3??-Acetoxydiversifolol

C18H28O5 (324.1936638)


   
   

6alpha-acetoxy-1beta,4alpha-dihydroxy-eudesm-11(13)-en-12,8alpha-olide

6alpha-acetoxy-1beta,4alpha-dihydroxy-eudesm-11(13)-en-12,8alpha-olide

C17H24O6 (324.1572804)


   
   

10-epidihydrobotrydial

10-epidihydrobotrydial

C18H28O5 (324.1936638)


   

(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-ethoxy-3-methylbutan-2-ol|lenisin C

(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-ethoxy-3-methylbutan-2-ol|lenisin C

C18H28O5 (324.1936638)


   

(1S)-2xi-(6-Methoxy-[4]chinolyl)-6endo-vinyl-1-aza-bicyclo[3.2.2]nonan-3xi-ol|(1S)-2xi-(6-methoxy-[4]quinolyl)-6endo-vinyl-1-aza-bicyclo[3.2.2]nonan-3xi-ol

(1S)-2xi-(6-Methoxy-[4]chinolyl)-6endo-vinyl-1-aza-bicyclo[3.2.2]nonan-3xi-ol|(1S)-2xi-(6-methoxy-[4]quinolyl)-6endo-vinyl-1-aza-bicyclo[3.2.2]nonan-3xi-ol

C20H24N2O2 (324.18376839999996)


   

(5R,6R,7R,8S,10S,11S)-8-acetoxy-14,15-dihydroxyelema-1,3-dien-6,12-olide

(5R,6R,7R,8S,10S,11S)-8-acetoxy-14,15-dihydroxyelema-1,3-dien-6,12-olide

C17H24O6 (324.1572804)


   

1-acetoxy-6alpha,14-dihydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide

1-acetoxy-6alpha,14-dihydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide

C17H24O6 (324.1572804)


   

5alpha-hydroperoxy-9beta-acetoxyeudesm-4(15),11(13)-dien-12-oic acid

5alpha-hydroperoxy-9beta-acetoxyeudesm-4(15),11(13)-dien-12-oic acid

C17H24O6 (324.1572804)


   
   

1,2-Dehydro-beninin|1,2-Dehydrobeninin|1,2-didehydro-beninine|ent-6beta,21-epoxy-17-methoxy-1,2-didehydro-aspidospermidine

1,2-Dehydro-beninin|1,2-Dehydrobeninin|1,2-didehydro-beninine|ent-6beta,21-epoxy-17-methoxy-1,2-didehydro-aspidospermidine

C20H24N2O2 (324.18376839999996)


   

2-(2-Methoxy-4-methylphenyl)glycerol 1-isobutyrate 3-acetate

2-(2-Methoxy-4-methylphenyl)glycerol 1-isobutyrate 3-acetate

C17H24O6 (324.1572804)


   

2-hydroxy-4-acetylhymenoratin

2-hydroxy-4-acetylhymenoratin

C17H24O6 (324.1572804)


   
   
   

11beta,13-dihydroxyepitulipinolide

11beta,13-dihydroxyepitulipinolide

C17H24O6 (324.1572804)


   

khusinol benzoate|Khusinolbenzoat

khusinol benzoate|Khusinolbenzoat

C22H28O2 (324.2089188)


   

3-(3-ethenylpiperidin-4-yl)-1-(6-methoxyquinolin-4-yl)propan-1-one

3-(3-ethenylpiperidin-4-yl)-1-(6-methoxyquinolin-4-yl)propan-1-one

C20H24N2O2 (324.18376839999996)


   

Dianilide-3-Methylheptanedioic acid

Dianilide-3-Methylheptanedioic acid

C20H24N2O2 (324.18376839999996)


   

8-Oxo,15alpha-hydroxy-(+)-Aristoteline|aristolasicolone

8-Oxo,15alpha-hydroxy-(+)-Aristoteline|aristolasicolone

C20H24N2O2 (324.18376839999996)


   
   

1-Ac-1,5,8-Trihydroxy-4(15)-eudesmen-12,6-olide|1alpha-acetoxy-5beta,8alpha-dihydroxyeudesm-4(15)-en-6beta,11betaH-12,6-olide

1-Ac-1,5,8-Trihydroxy-4(15)-eudesmen-12,6-olide|1alpha-acetoxy-5beta,8alpha-dihydroxyeudesm-4(15)-en-6beta,11betaH-12,6-olide

C17H24O6 (324.1572804)


   

2-phenyl-N-[4-[(2-phenylacetyl)amino]butyl]acetamide

2-phenyl-N-[4-[(2-phenylacetyl)amino]butyl]acetamide

C20H24N2O2 (324.18376839999996)


   
   

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

C18H28O5 (324.1936638)


   

Strema

(R)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

C20H24N2O2 (324.18376839999996)


Quinine Sulfate is the sulfate salt form of the quinidine alkaloid isolate quinine. Quinine has many mechanisms of action, including reduction of oxygen intake and carbohydrate metabolism; disruption of DNA replication and transcription via DNA intercalation; and reduction of the excitability of muscle fibers via alteration of calcium distribution. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04) An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Citalopram

Citalopram

C20H21FN2O (324.1637828)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 1513 CONFIDENCE standard compound; INTERNAL_ID 4118

   

Quinine

Quinine

C20H24N2O2 (324.18376839999996)


CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5966; ORIGINAL_PRECURSOR_SCAN_NO 5964 P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BC - Methanolquinolines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5977; ORIGINAL_PRECURSOR_SCAN_NO 5975 CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5998; ORIGINAL_PRECURSOR_SCAN_NO 5996 CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5996; ORIGINAL_PRECURSOR_SCAN_NO 5994 CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6003; ORIGINAL_PRECURSOR_SCAN_NO 6001 CONFIDENCE standard compound; INTERNAL_ID 270; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6016; ORIGINAL_PRECURSOR_SCAN_NO 6013 Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Cinchona alkaloids, Indole alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.728 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.722 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.721 Quinine is an alkaloid derived from the bark of the cinchona tree, acts as an anti-malaria agent. Quinine is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2]. Quinine is an alkaloid derived from the bark of the cinchona tree, acts as an anti-malaria agent. Quinine is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].

   

Bindarit

Bindarit

C19H20N2O3 (324.147385)


D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C29629 - Combination Medication > C29634 - Antirheumatic Preparation D000893 - Anti-Inflammatory Agents Bindarit (AF2838) is a selective inhibitor of the monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7, and MCP-2/CCL8, and no effect on other CC and CXC chemokines such as MIP-1α/CCL3, MIP-1β/CCL4, MIP-3/CCL23. Bindarit also has anti-inflammatory activity[1].

   

C20H24N2O2_6-Methoxycinchonan-9-ol

NCGC00384512-01_C20H24N2O2_6-Methoxycinchonan-9-ol

C20H24N2O2 (324.18376839999996)


   

C17H24O6_2-Butenoic acid, 2-methyl-, (1S,5R,6S)-5-(acetyloxy)-3-(hydroxymethyl)-6-(1-methylethyl)-4-oxo-2-cyclohexen-1-yl ester, (2E)

NCGC00180769-03_C17H24O6_2-Butenoic acid, 2-methyl-, (1S,5R,6S)-5-(acetyloxy)-3-(hydroxymethyl)-6-(1-methylethyl)-4-oxo-2-cyclohexen-1-yl ester, (2E)-

C17H24O6 (324.1572804)


   

Escitalopram

Escitalopram

C20H21FN2O (324.1637828)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression[1][2].

   
   

Quinidine

Quinidine

C20H24N2O2 (324.18376839999996)


Annotation level-1 Quinidine (15\\% dihydroquinidine) is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine is also a K+ channel blocker with an IC50 of 19.9 μM, and can induce apoptosis. Quinidine can be used for malaria research[1][2][3][4]. Quinidine (15\% dihydroquinidine) is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine is also a K+ channel blocker with an IC50 of 19.9 μM, and can induce apoptosis. Quinidine can be used for malaria research[1][2][3][4].

   

[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol

C20H24N2O2 (324.18376839999996)


   

CA5PE2C

CA5PE2C

C17H24O6 (324.1572804)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); The position of the carboxylic group was assigned arbitrarily; locations of branching points are undetermined; Digitised from figure: approximate intensities

   

CA6PE2

CA6PE2

C18H28O5 (324.1936638)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); The position of the carboxylic group was assigned arbitrarily; locations of branching points are undetermined; Digitised from figure: approximate intensities

   

15-Monoacetoxyscirpenol

15-Monoacetoxyscirpenol

C17H24O6 (324.1572804)


   

[(1R,5S,6S)-5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] (E)-2-methylbut-2-enoate_major

[(1R,5S,6S)-5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] (E)-2-methylbut-2-enoate_major

C17H24O6 (324.1572804)


   

h_295_6a_Hydroxy_gestrinone

h_295_6a_Hydroxy_gestrinone

C21H24O3 (324.1725354)


   

Dihydroxycarteolol M1

Dihydroxycarteolol M1

C16H24N2O5 (324.1685134)


   

Dihydroxycarteolol M2

Dihydroxycarteolol M2

C16H24N2O5 (324.1685134)


   

γ-Hydroxyphenylbutazone

γ-Hydroxyphenylbutazone

C19H20N2O3 (324.147385)


   

13-ethyl-2,17-dihydroxy-18,19-Dinorpregna-4,9,11-trien-20-yn-3-one

13-ethyl-2,17-dihydroxy-18,19-Dinorpregna-4,9,11-trien-20-yn-3-one

C21H24O3 (324.1725354)


   

13-ethyl-16,17-dihydroxy-18,19-Dinorpregna-4,9,11-trien-20-yn-3-one

13-ethyl-16,17-dihydroxy-18,19-Dinorpregna-4,9,11-trien-20-yn-3-one

C21H24O3 (324.1725354)


   

13-Ethyl-6a,17-dihydroxy-18,19-dinor-17a-pregna-4,9,11-trien-20-yn-3-one

13-Ethyl-6a,17-dihydroxy-18,19-dinor-17a-pregna-4,9,11-trien-20-yn-3-one

C21H24O3 (324.1725354)


   
   

Lexapro

S-(+)-Citalopram

C20H21FN2O (324.1637828)


Escitalopram ((S)-Citalopram), the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram has ~30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram is an antidepressant for the research of major depression[1][2].

   
   

4,7,10,13-Docosatetraynoic acid

4,7,10,13-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

5,8,11,14-Docosatetraynoic acid

5,8,11,14-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

7,10,13,16-Docosatetraynoic acid

7,10,13,16-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

C18H28O5 (324.1936638)


   

Dinor-PGE2

2,3-dinor-9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid

C18H28O5 (324.1936638)


   

Dinor-PGD2

2,3-dinor-9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid

C18H28O5 (324.1936638)


   

Idebenone Metabolite (QS-8)

Idebenone Metabolite (QS-8)

C17H24O6 (324.1572804)


   

AF Toxin II

(2E,4Z,6E)-8-[(2-hydroxy-3-methylpentanoyl)oxy]-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid

C17H24O6 (324.1572804)


   

Lactapiperanol D

10-hydroxy-13-methoxy-3,6,6-trimethyl-12-oxatetracyclo[8.3.0.0^{1,3}.0^{4,8}]tridecan-9-yl acetate

C18H28O5 (324.1936638)


   

3-Acetoxyscirpene-4,15-diol

11-hydroxy-2-(hydroxymethyl)-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0^{2,7}]dodecan]-5-en-10-yl acetate

C17H24O6 (324.1572804)


D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

Blumealactone C

2-hydroxy-5,9-dimethyl-14-methylidene-13-oxo-4,12-dioxatricyclo[9.3.0.0^{3,5}]tetradecan-10-yl acetate

C17H24O6 (324.1572804)


   

4-Acetoxyscirpene-3,15-diol

10-hydroxy-2-(hydroxymethyl)-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0^{2,7}]dodecan]-5-en-11-yl acetate

C17H24O6 (324.1572804)


D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

Deacetylanguidin

10,11-dihydroxy-1,5-dimethyl-8-oxaspiro[oxirane-2,12-tricyclo[7.2.1.0^{2,7}]dodecan]-5-en-2-ylmethyl acetate

C17H24O6 (324.1572804)


D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

Cibaric acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


   

16:0(7Cl,8Cl)

7,8-dichloro-hexadecanoic acid

C16H30Cl2O2 (324.16227399999997)


   
   

FA 22:8

7,10,13,16-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

FA 18:4;O3

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

C18H28O5 (324.1936638)


   

amphotalide

amphotalide

C19H20N2O3 (324.147385)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

abietic acid sodium salt

abietic acid sodium salt

C20H29NaO2 (324.2065134)


   

3-Ethyl-1,1,1,5,5,5-hexamethyl-3-trimethylsilanyloxy-trisiloxane

3-Ethyl-1,1,1,5,5,5-hexamethyl-3-trimethylsilanyloxy-trisiloxane

C11H32O3Si4 (324.1428442)


   

Methyl 4-anilino-1-benzyl-4-piperidinecarboxylate

Methyl 4-anilino-1-benzyl-4-piperidinecarboxylate

C20H24N2O2 (324.18376839999996)


   

3,5-Dimethyl-3,5-ditert-butyldiphenoquinone

3,5-Dimethyl-3,5-ditert-butyldiphenoquinone

C22H28O2 (324.2089188)


   

(3-BOC-AMINO-AZETIDIN-1-YL)-P-TOLYL-ACETICACID

(3-BOC-AMINO-AZETIDIN-1-YL)-P-TOLYL-ACETICACID

C16H24N2O5 (324.1685134)


   

Glyoctamide

Glyoctamide

C16H24N2O3S (324.1507554)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

5-Tert-Butyl 2-Ethyl 3-Amino-6,6-Dimethylpyrrolo[3,4-C]Pyrazole-2,5(4H,6H)-Dicarboxylate

5-Tert-Butyl 2-Ethyl 3-Amino-6,6-Dimethylpyrrolo[3,4-C]Pyrazole-2,5(4H,6H)-Dicarboxylate

C15H24N4O4 (324.1797464)


   

1,1,1-trimethylol ethane trimethacrylate

1,1,1-trimethylol ethane trimethacrylate

C17H24O6 (324.1572804)


   

viquidil

viquidil

C20H24N2O2 (324.18376839999996)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   

3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile

3-Anilino-2-(3,4,5-trimethoxybenzyl)acrylonitrile

C19H20N2O3 (324.147385)


   

2-(4-BOC-AMINOPIPERIDIN-1-YL)-2-(FURAN-&

2-(4-BOC-AMINOPIPERIDIN-1-YL)-2-(FURAN-&

C16H24N2O5 (324.1685134)


   

Bupivacaine hydrochloride

Bupivacaine hydrochloride

C18H29ClN2O (324.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents Bupivacaine hydrochloride is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride can be used for the research of chronic pain[1][2][3].

   

TERT-BUTYL SPIRO[INDOLINE-3,4-PIPERIDINE]-1-CARBOXYLATE HYDROCHLORIDE

TERT-BUTYL SPIRO[INDOLINE-3,4-PIPERIDINE]-1-CARBOXYLATE HYDROCHLORIDE

C17H25ClN2O2 (324.160446)


   

3-[3-(4-phenylpiperazin-1-yl)propoxy]benzaldehyde

3-[3-(4-phenylpiperazin-1-yl)propoxy]benzaldehyde

C20H24N2O2 (324.18376839999996)


   

Piperazine 7-theophyllineacetate

Piperazine 7-theophyllineacetate

C13H20N6O4 (324.154596)


   

1-(2-THIOPHEN-2-YL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLICACID

1-(2-THIOPHEN-2-YL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLICACID

C12H28O6Si2 (324.14243480000005)


   

(+)-NEOMENTHYLDIPHENYLPHOSPHINE

(+)-NEOMENTHYLDIPHENYLPHOSPHINE

C22H29P (324.2006764)


   

N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]benzamide

N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]benzamide

C18H21BN2O3 (324.1645146000001)


   

2-Bromo-1,3,5-tri-tert-butylbenzene

Benzene,2-bromo-1,3,5-tris(1,1-dimethylethyl)-

C18H29Br (324.1452494)


   

2-(benzylmethylamino)pyridine-5-boronic acid pinacol ester

2-(benzylmethylamino)pyridine-5-boronic acid pinacol ester

C19H25BN2O2 (324.200898)


   
   

tert-butyl 2-phenyl-1,2,3,4-tetrahydro-1,5-benzodiazepine-5-carboxylate

tert-butyl 2-phenyl-1,2,3,4-tetrahydro-1,5-benzodiazepine-5-carboxylate

C20H24N2O2 (324.18376839999996)


   

4-Ethyl-4-(3,4,5-trifluorophenyl)bi(cyclohexane)

4-Ethyl-4-(3,4,5-trifluorophenyl)bi(cyclohexane)

C20H27F3 (324.2064738)


   

6-(4-Methylbenzylamino)pyridine-3-boronic acid pinacol ester

6-(4-Methylbenzylamino)pyridine-3-boronic acid pinacol ester

C19H25BN2O2 (324.200898)


   

4-Methyl-1-trityl-1H-imidazole

4-Methyl-1-trityl-1H-imidazole

C23H20N2 (324.16264)


   

trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane

trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane

C15H29BN2O3Si (324.2040394)


   

Dichloro(dioctyl)silane

Dichloro(dioctyl)silane

C16H34Cl2Si (324.1806704)


   

1-Hexadecanesulfonylchloride

1-Hexadecanesulfonylchloride

C16H33ClO2S (324.1889668)


   
   

1-Bromo-4-dodecylbenzene

1-Bromo-4-dodecylbenzene

C18H29Br (324.1452494)


   

2-[1,4]DIAZEPAN-1-YL-1-(4-FLUORO-BENZYL)-1H-BENZOIMIDAZOLE

2-[1,4]DIAZEPAN-1-YL-1-(4-FLUORO-BENZYL)-1H-BENZOIMIDAZOLE

C19H21FN4 (324.1750158)


   

4-CHLORO-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-OL

4-CHLORO-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-OL

C16H25ClN2OSi (324.142459)


   

1-(3-FLUOROPHENYL)-5-[(PIPERIDIN-1-YL)METHYL]-1H-BENZIMIDAZOL-2-YL]AMINE

1-(3-FLUOROPHENYL)-5-[(PIPERIDIN-1-YL)METHYL]-1H-BENZIMIDAZOL-2-YL]AMINE

C19H21FN4 (324.1750158)


   

ALLYL METHACRYLATES CROSSPOLYMER

ALLYL METHACRYLATES CROSSPOLYMER

C17H24O6 (324.1572804)


   
   

sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-nonyl-1H-imidazolium hydroxide

sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-nonyl-1H-imidazolium hydroxide

C15H29N2NaO4 (324.20249140000004)


   
   

3-3-Dimethyl-5-5-ditert-butyl-diphenoquinone

3-3-Dimethyl-5-5-ditert-butyl-diphenoquinone

C22H28O2 (324.2089188)


   

1-BOC-4-(CARBOXY-FURAN-2-YL-METHYL)-[1,4]DIAZEPANE

1-BOC-4-(CARBOXY-FURAN-2-YL-METHYL)-[1,4]DIAZEPANE

C16H24N2O5 (324.1685134)


   

1,4-bis-(Phenylmethyl)-2-piperazinecarboxylic acid methyl ester

1,4-bis-(Phenylmethyl)-2-piperazinecarboxylic acid methyl ester

C20H24N2O2 (324.18376839999996)


   

4-dodecoxybenzoyl chloride

4-dodecoxybenzoyl chloride

C19H29ClO2 (324.1855964)


   

Dichloro[bis(2-ethylhexyl)]silane

Dichloro[bis(2-ethylhexyl)]silane

C16H34Cl2Si (324.1806704)


   

N-PYRIDIN-4-YL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

N-PYRIDIN-4-YL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE

C18H21BN2O3 (324.1645146000001)


   

2-((4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

2-((4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)-3H-PYRROLO[2,3-D]PYRIMIDIN-4(7H)-ONE

C17H20N6O (324.169851)


   

Benzoic acid, 2-amino-4-Methoxy-5-[3-(4-Morpholinyl)propoxy]-, Methyl ester

Benzoic acid, 2-amino-4-Methoxy-5-[3-(4-Morpholinyl)propoxy]-, Methyl ester

C16H24N2O5 (324.1685134)


   

1-CYCLOHEXYL-2-(3-FURANYL)-1H-BENZIMIDAZOLE-5-CARBOXYLIC ACID, METHYL ESTER

1-CYCLOHEXYL-2-(3-FURANYL)-1H-BENZIMIDAZOLE-5-CARBOXYLIC ACID, METHYL ESTER

C19H20N2O3 (324.147385)


   

2-[(2-tert-Butyldimethylsilyl)thienyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-[(2-tert-Butyldimethylsilyl)thienyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C16H29BO2SSi (324.17504840000004)


   

2-Benzyloxy-5-methylphenylboronic acid pinacol ester

2-Benzyloxy-5-methylphenylboronic acid pinacol ester

C20H25BO3 (324.189665)


   

Di-tert-butyl (6-amino-2-Methylpyrimidin-4-yl)carbamate

Di-tert-butyl (6-amino-2-Methylpyrimidin-4-yl)carbamate

C15H24N4O4 (324.1797464)


   

(R)-citalopram

(R)-(-)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON

C20H21FN2O (324.1637828)


   

1,2-Ethanediol - 1,1-methylenebis(4-isocyanatocyclohexane) (1:1)

1,2-Ethanediol - 1,1-methylenebis(4-isocyanatocyclohexane) (1:1)

C17H28N2O4 (324.20489680000003)


   

1,5-Diphenyl-3-(2-phenylvinyl)-4,5-dihydro-1H-pyrazole

1,5-Diphenyl-3-(2-phenylvinyl)-4,5-dihydro-1H-pyrazole

C23H20N2 (324.16264)


   

Propylene glycol, fumaric acid, dicyclopentadiene polymer

Propylene glycol, fumaric acid, dicyclopentadiene polymer

C17H24O6 (324.1572804)


   

Acefylline Piperazine

Acefylline Piperazine

C13H20N6O4 (324.154596)


   

1-Benzyl-4-benzyloxycarbonylaminopiperidine

1-Benzyl-4-benzyloxycarbonylaminopiperidine

C20H24N2O2 (324.18376839999996)


   
   

1-(2-HYDROXY-1-METHYL-2-PHENYL-ETHYL)-4-PHENYLAMINO-PIPERIDIN-2-ONE

1-(2-HYDROXY-1-METHYL-2-PHENYL-ETHYL)-4-PHENYLAMINO-PIPERIDIN-2-ONE

C20H24N2O2 (324.18376839999996)


   

2-[3-(4-tert-Butoxycarbonyl-1-piperazinyl)-2-pyrazinyloxy]ethanol

2-[3-(4-tert-Butoxycarbonyl-1-piperazinyl)-2-pyrazinyloxy]ethanol

C15H24N4O4 (324.1797464)


   

4,4,7-TRIETHOXY-7-METHYL-3,8-DIOXA-4,7-DISILADECANE

4,4,7-TRIETHOXY-7-METHYL-3,8-DIOXA-4,7-DISILADECANE

C13H32O5Si2 (324.1788182)


   
   

1-benzyloxy-3-propionyloxy-2-(propionyloxy)methoxypropane

1-benzyloxy-3-propionyloxy-2-(propionyloxy)methoxypropane

C17H24O6 (324.1572804)


   
   

N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide

N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide

C18H21BN2O3 (324.1645146000001)


   

2-(4-(benzyloxy)-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(benzyloxy)-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C20H25BO3 (324.189665)


   

CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOXANE

CARBINOL (HYDROXYL) TERMINATED POLYDIMETHYLSILOXANE

C12H32O4Si3 (324.1608312)


   
   

1H-BenziMidazole-7-carboxaMide, 2-[(2S)-2-Methyl-2-pyrrolidinyl]-, hydrochloride (1:2)

1H-BenziMidazole-7-carboxaMide, 2-[(2S)-2-Methyl-2-pyrrolidinyl]-, hydrochloride (1:2)

C13H26Cl2N4O (324.1483566)


   

4,4-Difluoro-1,3,5,7-tetramethyl-8-phenyl-4-bora-3a,4a-diaza-s-indacene

Difluoro{2-[(3,5-dimethyl-2H-pyrrol-2-ylidene-N)phenylmethyl]-3,5-dimethyl-1H-pyrrolato-N}boron

C19H19BF2N2 (324.1609268)


   

(S)-4-(1-HYDROXYMETHYL-PROPYLAMINO)BENZONITRILE

(S)-4-(1-HYDROXYMETHYL-PROPYLAMINO)BENZONITRILE

C19H20N2O3 (324.147385)


   

2,3,4,6,7,8,9,10-Octahydro-1H-pyrimido[1,2-a]azepin-5-ium 4-methy lbenzenesulfonate

2,3,4,6,7,8,9,10-Octahydro-1H-pyrimido[1,2-a]azepin-5-ium 4-methy lbenzenesulfonate

C16H24N2O3S (324.1507554)


   
   

Levobupivacaine hydrochloride

Levobupivacaine hydrochloride

C18H29ClN2O (324.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE

C15H29BN2O3Si (324.2040394)


   

2-tridecoxyethyl dihydrogen phosphate

2-tridecoxyethyl dihydrogen phosphate

C15H33O5P (324.2065498)


   

N,N-Disalicylidene-1,6-hexanediamine

N,N-Disalicylidene-1,6-hexanediamine

C20H24N2O2 (324.18376839999996)


   

((2S)-1-(-2-NITROVINYL)-2,3-DIPHENYLPYRROLIDIN-2-YL)METHANOL

((2S)-1-(-2-NITROVINYL)-2,3-DIPHENYLPYRROLIDIN-2-YL)METHANOL

C19H20N2O3 (324.147385)


   

4-(6-AMINO-5-NITRO-4-PYRIMIDINYL)-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER

4-(6-AMINO-5-NITRO-4-PYRIMIDINYL)-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER

C13H20N6O4 (324.154596)


   

1,2,3,4-Butanetetrol,1-[5-[(2S,3R)-2,3,4-trihydroxybutyl]-2-pyrazinyl]-, (1R,2S,3R)-

1,2,3,4-Butanetetrol,1-[5-[(2S,3R)-2,3,4-trihydroxybutyl]-2-pyrazinyl]-, (1R,2S,3R)-

C12H24N2O8 (324.15325839999997)


   

Antibiotic 1233A

Antibiotic 1233A

C18H28O5 (324.1936638)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

   
   

2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate

2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl 2-amino-3-methylbutanoate

C13H20N6O4 (324.154596)


   
   

4-Diphenylacetoxy-1,1-dimethylpiperidinium

4-Diphenylacetoxy-1,1-dimethylpiperidinium

C21H26NO2+ (324.19634360000003)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

(R)-(+)-Bupivacaine Hydrochloride

(R)-(+)-Bupivacaine Hydrochloride

C18H29ClN2O (324.1968294)


   

1-[2-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-oxoethyl]pyrrolidine-2,5-dione

1-[2-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-oxoethyl]pyrrolidine-2,5-dione

C19H20N2O3 (324.147385)


   
   

O-Acetaldehydyl-hexaethylene glycol

O-Acetaldehydyl-hexaethylene glycol

C14H28O8 (324.1784088)


   

N-[2-(4-morpholinyl)ethyl]-6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-amine

N-[2-(4-morpholinyl)ethyl]-6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-amine

C19H24N4O (324.19500139999997)


   
   

2,3,5,5,6,6,8,9-Octamethyl-5,6-dihydrodibenzo[c,e][1,2]disiline

2,3,5,5,6,6,8,9-Octamethyl-5,6-dihydrodibenzo[c,e][1,2]disiline

C20H28Si2 (324.1729448)


   

1-[3-(3,4-Dimethoxyphenyl)imidazo[1,2-b]pyridazin-6-yl]pyrrolidine

1-[3-(3,4-Dimethoxyphenyl)imidazo[1,2-b]pyridazin-6-yl]pyrrolidine

C18H20N4O2 (324.158618)


   

(4R)-4-(3-Hydroxyphenyl)-N,N,7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide

(4R)-4-(3-Hydroxyphenyl)-N,N,7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide

C20H24N2O2 (324.18376839999996)


   

2-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-6-isobutoxybenzenolate

2-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-6-isobutoxybenzenolate

C18H20N4O2 (324.158618)


   

Valacyclovir

Valacyclovir

C13H20N6O4 (324.154596)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Tecastemizole

Tecastemizole

C19H21FN4 (324.1750158)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Tecastemizole (Norastemizole), a major metabolite of Astemizole, is a potent and selective H1 receptor antagonist. Tecastemizole shows anti-inflammatory activities[1].

   

Ditazole

2-[(4,5-diphenyl-1,3-oxazol-2-yl)-(2-hydroxyethyl)amino]ethanol

C19H20N2O3 (324.147385)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent

   

Methyl 7-{4-[2-(2-hydroxyethoxy)ethoxy]phenyl}heptanoate

Methyl 7-{4-[2-(2-hydroxyethoxy)ethoxy]phenyl}heptanoate

C18H28O5 (324.1936638)


   
   

(15-Ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl)methanol

(15-Ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl)methanol

C20H24N2O2 (324.18376839999996)


   

[11-Hydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-10-yl] acetate

[11-Hydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-10-yl] acetate

C17H24O6 (324.1572804)


   

4-Hydroxy-6-(8-hydroxy-2-oxotridecyl)pyran-2-one

4-Hydroxy-6-(8-hydroxy-2-oxotridecyl)pyran-2-one

C18H28O5 (324.1936638)


   

(2E)-4-{methyl[3-phenyl-3-(pyridin-2-yl)propyl]amino}-4-oxobut-2-enoic acid

(2E)-4-{methyl[3-phenyl-3-(pyridin-2-yl)propyl]amino}-4-oxobut-2-enoic acid

C19H20N2O3 (324.147385)


   

(R)-(6-Methoxy-4-quinolyl)-(5-vinylquinuclidin-2-yl)methanol

(R)-(6-Methoxy-4-quinolyl)-(5-vinylquinuclidin-2-yl)methanol

C20H24N2O2 (324.18376839999996)


   
   

methyl (1S,17R,18S)-18-ethyl-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate

methyl (1S,17R,18S)-18-ethyl-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate

C20H24N2O2 (324.18376839999996)


   

2-Deamino-2-hydroxy-6-dehydroparomamine(2+)

2-Deamino-2-hydroxy-6-dehydroparomamine(2+)

C12H24N2O8+2 (324.15325839999997)


   
   

3alpha-Acetoxy-7alpha,15-dihydroxy-12,13-epoxytrichothec-9-ene

3alpha-Acetoxy-7alpha,15-dihydroxy-12,13-epoxytrichothec-9-ene

C17H24O6 (324.1572804)


   

[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2,6-diamino-5-hydroxyhexanoate

[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2,6-diamino-5-hydroxyhexanoate

C12H24N2O8 (324.15325839999997)


   

2,6-diamino-2-[3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]hexanoic acid

2,6-diamino-2-[3,4,5,6-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]hexanoic acid

C12H24N2O8 (324.15325839999997)


   

[3-carboxy-2-[(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoyl]oxypropyl]-trimethylazanium

C17H26NO5+ (324.1810886)


   

20(R)-tubotaiwine

20(R)-tubotaiwine

C20H24N2O2 (324.18376839999996)


A natural product found in Alstonia spatulata.

   

8-(9-methyl-5H-pyrimido[5,4-b]indol-4-yl)-1,4-dioxa-8-azaspiro[4.5]decane

8-(9-methyl-5H-pyrimido[5,4-b]indol-4-yl)-1,4-dioxa-8-azaspiro[4.5]decane

C18H20N4O2 (324.158618)


   

6-Amino-4-(2-ethoxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

6-Amino-4-(2-ethoxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile

C18H20N4O2 (324.158618)


   

Guignardone N

Guignardone N

C17H24O6 (324.1572804)


A meroterpenoid found in Guignardia and Fusarium species and shown to exhibit inhibitory activity against Candida albicans growth.

   

N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide

N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide

C16H24N2O3S (324.1507554)


   

3-Methyl-N-[(E)-[4-[(4-methylpyridin-2-yl)amino]-4-oxobutan-2-ylidene]amino]benzamide

3-Methyl-N-[(E)-[4-[(4-methylpyridin-2-yl)amino]-4-oxobutan-2-ylidene]amino]benzamide

C18H20N4O2 (324.158618)


   

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol

[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol

C20H24N2O2 (324.18376839999996)


   

N-[5-[2-(4-morpholinyl)ethyl]-1,3,4-thiadiazol-2-yl]cyclohexanecarboxamide

N-[5-[2-(4-morpholinyl)ethyl]-1,3,4-thiadiazol-2-yl]cyclohexanecarboxamide

C15H24N4O2S (324.1619884)


   

(4-Benzyl-piperazin-1-yl)-(4-nitro-benzylidene)-amine

(4-Benzyl-piperazin-1-yl)-(4-nitro-benzylidene)-amine

C18H20N4O2 (324.158618)


   

N-[6-[[cyclohexyl(oxo)methyl]amino]-3-pyridinyl]-2-pyridinecarboxamide

N-[6-[[cyclohexyl(oxo)methyl]amino]-3-pyridinyl]-2-pyridinecarboxamide

C18H20N4O2 (324.158618)


   

N-(2-ethyl-6-methylphenyl)-2-(4-methyl-1-oxo-2-pyrrolo[1,2-d][1,2,4]triazinyl)acetamide

N-(2-ethyl-6-methylphenyl)-2-(4-methyl-1-oxo-2-pyrrolo[1,2-d][1,2,4]triazinyl)acetamide

C18H20N4O2 (324.158618)


   

1-(4-Benzylpiperazin-1-yl)-2-(pyridin-2-ylamino)propan-1-one

1-(4-Benzylpiperazin-1-yl)-2-(pyridin-2-ylamino)propan-1-one

C19H24N4O (324.19500139999997)


   

[4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-2-yl)phenyl]-N-methylmethanaminium

[4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-2-yl)phenyl]-N-methylmethanaminium

C19H19FN3O+ (324.1512076)


   

(6E)-8-[(1R,5R,6R)-5-hydroxy-4-(hydroxymethyl)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-2,6-dimethyloct-6-enoic acid

(6E)-8-[(1R,5R,6R)-5-hydroxy-4-(hydroxymethyl)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-2,6-dimethyloct-6-enoic acid

C17H24O6 (324.1572804)


   

N-[2-(4-aminophenyl)ethyl]-4-phenylisonipecotic acid

N-[2-(4-aminophenyl)ethyl]-4-phenylisonipecotic acid

C20H24N2O2 (324.18376839999996)


   

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

methyl (5E,6R,7S)-5-ethylidene-1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole-7-carboxylate

methyl (5E,6R,7S)-5-ethylidene-1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole-7-carboxylate

C20H24N2O2 (324.18376839999996)


   

methyl (5E,6R,7R)-5-ethylidene-1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole-7-carboxylate

methyl (5E,6R,7R)-5-ethylidene-1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole-7-carboxylate

C20H24N2O2 (324.18376839999996)


   

5,6-dihydroxy-1-[(2S)-4-phenylbutan-2-yl]indole-7-carboxamide

5,6-dihydroxy-1-[(2S)-4-phenylbutan-2-yl]indole-7-carboxamide

C19H20N2O3 (324.147385)


   

(3R,5R)-7-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

(3R,5R)-7-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

C18H28O5 (324.1936638)


   

(6-Methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol

(6-Methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol

C20H24N2O2 (324.18376839999996)


   

(3S)-4alpha-Isopropyl-3alpha,5beta-dihydroxy-1-[(hydroxy)methyl]-1-cyclohexen-6-one 3-[(E)-2-methyl-2-butenoate]5-acetate

(3S)-4alpha-Isopropyl-3alpha,5beta-dihydroxy-1-[(hydroxy)methyl]-1-cyclohexen-6-one 3-[(E)-2-methyl-2-butenoate]5-acetate

C17H24O6 (324.1572804)


   

3,5,7-Trihydroxy-p-menth-1-en-6-one, 5-Tigloyl, 3

3,5,7-Trihydroxy-p-menth-1-en-6-one, 5-Tigloyl, 3

C17H24O6 (324.1572804)


   

[(15E)-15-ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl]methanol

[(15E)-15-ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl]methanol

C20H24N2O2 (324.18376839999996)


   

2,3,5,6-Benzo-1,1,4,4-tetraethyl-1,4-disilacyclohexa-2,5-diene

2,3,5,6-Benzo-1,1,4,4-tetraethyl-1,4-disilacyclohexa-2,5-diene

C20H28Si2 (324.1729448)


   

2-[(1R,3S,8R,11S,13R,14S)-14-[(Z)-prop-1-enoxy]-2,7,12-trioxatricyclo[9.5.0.03,8]hexadecan-13-yl]acetaldehyde

2-[(1R,3S,8R,11S,13R,14S)-14-[(Z)-prop-1-enoxy]-2,7,12-trioxatricyclo[9.5.0.03,8]hexadecan-13-yl]acetaldehyde

C18H28O5 (324.1936638)


   

G-29701

oxyphenbutazone

C19H20N2O3 (324.147385)


A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Oxyphenbutazone is a Phenylbutazone (HY-B0230) metabolite, with anti-inflammatory effect. Oxyphenbutazone is an orally active non-selective COX inhibitor. Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis[1][2].

   

Piperonyl sulfoxide

1,3-Benzodioxole,5-[2-(octylsulfinyl)propyl]-

C18H28O3S (324.1759058)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Anzemet

dolasetron

C19H20N2O3 (324.147385)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

   

Tetraneurin E

Tetraneurin E

C17H24O6 (324.1572804)


A sesquiterpene lactone that is a (3aS,9bS)-3-methylidenedecahydroazuleno[4,5-b]furan-2(3H)-one heterotricyclic ring system with a hydroxymethyl, hydroxy, acetate, and methyl group substituents at positions 6, 6a, 9, and 9a respectively.

   

2,3-Epoxymenaquinone

2,3-Epoxymenaquinone

C21H24O3 (324.1725354)


   
   

Desacetylanguidine

Desacetylanguidine

C17H24O6 (324.1572804)


D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins

   

(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxy-4-quinolinyl)methanol

(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxy-4-quinolinyl)methanol

C20H24N2O2 (324.18376839999996)


   

(2S)-6-amino-2-{N-hydroxy[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}hexanoic acid

(2S)-6-amino-2-{N-hydroxy[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}hexanoic acid

C12H24N2O8 (324.15325839999997)


   

Nitracrine

Nitracrine

C18H20N4O2 (324.158618)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000970 - Antineoplastic Agents

   

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


   

(S)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol

(S)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol

C20H24N2O2 (324.18376839999996)


   

20(S)-tubotaiwine

20(S)-tubotaiwine

C20H24N2O2 (324.18376839999996)


A natural product found in Alstonia spatulata.

   

2,3-dinor-prostaglandin E2

2,3-dinor-prostaglandin E2

C18H28O5 (324.1936638)


A prostanoid that is prostaglandin E2 lacking two methylenes in the carboxyalkyl chain.

   

(16R)-deshydroxymethyl-stemmadenine

(16R)-deshydroxymethyl-stemmadenine

C20H24N2O2 (324.18376839999996)


An organic heterotetracyclic compound that is 1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole in which position 5 is substituted by an ethylidene group and position 7R is substituted by a methoxycarbonyl group.

   

(16S)-deshydroxymethyl-stemmadenine

(16S)-deshydroxymethyl-stemmadenine

C20H24N2O2 (324.18376839999996)


An organic heterotetracyclic compound that is 1,4,5,6,7,8-hexahydro-2H-3,6-ethanoazonino[5,4-b]indole in which position 5 is substituted by an ethylidene group and position 7S is substituted by a methoxycarbonyl group.

   

yanuthone I

yanuthone I

C17H24O6 (324.1572804)


A class I yanuthone that is 5,6-epoxy-4-hydroxy-3-hydroxymethylcyclohex-2-en-1-one which is substituted at position 6 by a (2E)-7-carboxy-3-methyloct-2-en-1-yl group (the R,R,R stereoisomer).

   

DG(15:3)

DG(4:0_11:3)

C18H28O5 (324.1936638)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   

(1r,12r,13s,14s)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-7-ol

(1r,12r,13s,14s)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-7-ol

C20H24N2O2 (324.18376839999996)


   

(2e,4e)-5-[(1r,2s,3r,4r,4as,6r,8r,8as)-1,3,4-trihydroxy-2,6,8-trimethyl-octahydro-2h-naphthalen-1-yl]penta-2,4-dienoic acid

(2e,4e)-5-[(1r,2s,3r,4r,4as,6r,8r,8as)-1,3,4-trihydroxy-2,6,8-trimethyl-octahydro-2h-naphthalen-1-yl]penta-2,4-dienoic acid

C18H28O5 (324.1936638)


   

1-hydroxy-13,13-dimethoxy-6-methyl-1h,6h,7h,8h,9h,11ah,12h,14h,14ah-cyclopenta[f]oxacyclotridecan-4-one

1-hydroxy-13,13-dimethoxy-6-methyl-1h,6h,7h,8h,9h,11ah,12h,14h,14ah-cyclopenta[f]oxacyclotridecan-4-one

C18H28O5 (324.1936638)


   

(2z)-2-[(1-hydroxy-4-oxocyclohexyl)methyl]-3-[(4-methoxyphenyl)methyl]but-2-enedinitrile

(2z)-2-[(1-hydroxy-4-oxocyclohexyl)methyl]-3-[(4-methoxyphenyl)methyl]but-2-enedinitrile

C19H20N2O3 (324.147385)


   

2-[(1s,14r,15z)-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-15-ylidene]ethanol

2-[(1s,14r,15z)-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-15-ylidene]ethanol

C20H24N2O2 (324.18376839999996)


   

5-(acetyloxy)-3-(hydroxymethyl)-6-isopropyl-2-oxocyclohex-3-en-1-yl 2-methylbut-2-enoate

5-(acetyloxy)-3-(hydroxymethyl)-6-isopropyl-2-oxocyclohex-3-en-1-yl 2-methylbut-2-enoate

C17H24O6 (324.1572804)


   

methyl (14e)-14-ethylidene-2,12-diazapentacyclo[13.2.1.0¹,⁹.0³,⁸.0¹²,¹⁷]octadeca-3,5,7-triene-18-carboxylate

methyl (14e)-14-ethylidene-2,12-diazapentacyclo[13.2.1.0¹,⁹.0³,⁸.0¹²,¹⁷]octadeca-3,5,7-triene-18-carboxylate

C20H24N2O2 (324.18376839999996)


   

6-{2-[(1r,2s,6s)-1,2,6-trimethyl-3-oxocyclohexyl]ethyl}naphthalene-1,4-dione

6-{2-[(1r,2s,6s)-1,2,6-trimethyl-3-oxocyclohexyl]ethyl}naphthalene-1,4-dione

C21H24O3 (324.1725354)


   

(6e)-2,6-dimethyl-7-{9h-pyrido[3,4-b]indol-1-yl}hept-6-ene-2,3-diol

(6e)-2,6-dimethyl-7-{9h-pyrido[3,4-b]indol-1-yl}hept-6-ene-2,3-diol

C20H24N2O2 (324.18376839999996)


   

(1ar,2s,4ar,5s,6s,7as)-6-hydroxy-7a-(3-hydroxyprop-1-en-2-yl)-3,3,5-trimethyl-7-oxo-tetrahydro-2h-indeno[4,3a-b]oxiren-2-yl acetate

(1ar,2s,4ar,5s,6s,7as)-6-hydroxy-7a-(3-hydroxyprop-1-en-2-yl)-3,3,5-trimethyl-7-oxo-tetrahydro-2h-indeno[4,3a-b]oxiren-2-yl acetate

C17H24O6 (324.1572804)


   

(1r,9r,10s,12r,13e,16s,17s,18r)-13-ethylidene-6-methoxy-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-ol

(1r,9r,10s,12r,13e,16s,17s,18r)-13-ethylidene-6-methoxy-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-ol

C20H24N2O2 (324.18376839999996)


   

[(15e)-15-ethylidene-7-methoxy-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-13-yl]methanol

[(15e)-15-ethylidene-7-methoxy-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-13-yl]methanol

C20H24N2O2 (324.18376839999996)


   

4,11,13-trihydroxy-11-(hydroxymethyl)-3-methyl-6-(prop-1-en-2-yl)-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one

4,11,13-trihydroxy-11-(hydroxymethyl)-3-methyl-6-(prop-1-en-2-yl)-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one

C17H24O6 (324.1572804)


   

13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-one

13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-one

C20H24N2O2 (324.18376839999996)


   

3-hydroxy-2,4-dimethyl-5-oxo-6-(3,5,6-trimethyl-4-oxopyran-2-yl)heptanoic acid

3-hydroxy-2,4-dimethyl-5-oxo-6-(3,5,6-trimethyl-4-oxopyran-2-yl)heptanoic acid

C17H24O6 (324.1572804)


   

methyl 2-[(2r,4as,7r,8s,8ar)-7-(acetyloxy)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[(2r,4as,7r,8s,8ar)-7-(acetyloxy)-8-hydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O5 (324.1936638)


   

(3s)-6,8-dihydroxy-3-[(6r)-6-hydroxyheptyl]-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

(3s)-6,8-dihydroxy-3-[(6r)-6-hydroxyheptyl]-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid

C17H24O6 (324.1572804)


   

6-(2-{1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl}ethyl)naphthalene-1,4-dione

6-(2-{1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl}ethyl)naphthalene-1,4-dione

C21H24O3 (324.1725354)


   

6,9-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate

6,9-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

5,12-dihydroxy-8-methoxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one

5,12-dihydroxy-8-methoxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one

C18H28O5 (324.1936638)


   

(1r)-8-hydroxy-1,5,15-trimethyl-4,7,12-trioxapentacyclo[8.5.0.0³,⁵.0³,⁸.0¹¹,¹³]pentadecan-14-yl acetate

(1r)-8-hydroxy-1,5,15-trimethyl-4,7,12-trioxapentacyclo[8.5.0.0³,⁵.0³,⁸.0¹¹,¹³]pentadecan-14-yl acetate

C17H24O6 (324.1572804)


   

(2s,3r)-2-[(3,4-dimethoxyphenyl)methyl]-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran

(2s,3r)-2-[(3,4-dimethoxyphenyl)methyl]-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran

C21H24O3 (324.1725354)


   

6,8-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl acetate

6,8-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

(1r,9r,10s,12r,13e,16s,17s,18s)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-6,18-diol

(1r,9r,10s,12r,13e,16s,17s,18s)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-6,18-diol

C20H24N2O2 (324.18376839999996)


   

1-[(2r,3s,5r,6r,8r)-2,6-dihydroxy-4,9-dioxatricyclo[5.3.0.0³,⁵]dec-1(7)-en-8-yl]decan-2-one

1-[(2r,3s,5r,6r,8r)-2,6-dihydroxy-4,9-dioxatricyclo[5.3.0.0³,⁵]dec-1(7)-en-8-yl]decan-2-one

C18H28O5 (324.1936638)


   

6-{2-[(1r,2s,4s)-1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl]ethyl}naphthalene-1,4-dione

6-{2-[(1r,2s,4s)-1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl]ethyl}naphthalene-1,4-dione

C21H24O3 (324.1725354)


   

5,7-dimethoxy-1-(3-methylbut-2-en-1-yl)-9,10-dihydrophenanthren-2-ol

5,7-dimethoxy-1-(3-methylbut-2-en-1-yl)-9,10-dihydrophenanthren-2-ol

C21H24O3 (324.1725354)


   

7-hydroperoxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-5-yl acetate

7-hydroperoxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-5-yl acetate

C17H24O6 (324.1572804)


   

methyl 18-ethyl-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate

methyl 18-ethyl-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraene-10-carboxylate

C20H24N2O2 (324.18376839999996)


   

(1s,4r,6r,8s,9z,11r,14r)-9-(hydroxymethyl)-4,14-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-8-yl acetate

(1s,4r,6r,8s,9z,11r,14r)-9-(hydroxymethyl)-4,14-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-8-yl acetate

C17H24O6 (324.1572804)


   

methyl 14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6,9-tetraene-10-carboxylate

methyl 14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6,9-tetraene-10-carboxylate

C19H20N2O3 (324.147385)


   

(1r,9r,16r,21s)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid

(1r,9r,16r,21s)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid

C20H24N2O2 (324.18376839999996)


   

(1s,4r,6r,8s,11r,14r)-9-(hydroxymethyl)-4,14-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-8-yl acetate

(1s,4r,6r,8s,11r,14r)-9-(hydroxymethyl)-4,14-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-8-yl acetate

C17H24O6 (324.1572804)


   

2,6-dimethyl-7-{9h-pyrido[3,4-b]indol-1-yl}hept-6-ene-2,3-diol

2,6-dimethyl-7-{9h-pyrido[3,4-b]indol-1-yl}hept-6-ene-2,3-diol

C20H24N2O2 (324.18376839999996)


   

6-{2-[(1s,2r,6r)-1,2,6-trimethyl-3-oxocyclohexyl]ethyl}naphthalene-1,4-dione

6-{2-[(1s,2r,6r)-1,2,6-trimethyl-3-oxocyclohexyl]ethyl}naphthalene-1,4-dione

C21H24O3 (324.1725354)


   

13-hydroxy-11-methoxy-6-(2-methoxypropan-2-yl)-3-methyl-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one

13-hydroxy-11-methoxy-6-(2-methoxypropan-2-yl)-3-methyl-2-oxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-10-one

C18H28O5 (324.1936638)


   

(1r,12r,13s,14s,15e)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-7-ol

(1r,12r,13s,14s,15e)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-7-ol

C20H24N2O2 (324.18376839999996)


   

8,9-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,7h,8h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate

8,9-dihydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,7h,8h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

1-(3,5-dihydroxy-6-methoxy-2-methyloxan-3-yl)-3-methoxyhexane-1,4,5-triol

1-(3,5-dihydroxy-6-methoxy-2-methyloxan-3-yl)-3-methoxyhexane-1,4,5-triol

C14H28O8 (324.1784088)


   

1-[(1's,2'r,3r,7'r,9's)-2-hydroxy-4'-oxa-12'-azaspiro[indole-3,10'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-6'-yl]ethanone

1-[(1's,2'r,3r,7'r,9's)-2-hydroxy-4'-oxa-12'-azaspiro[indole-3,10'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-6'-yl]ethanone

C19H20N2O3 (324.147385)


   

15-ethyl-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁶]octadeca-2(10),4,6,8-tetraen-12-one

15-ethyl-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹¹,¹⁶]octadeca-2(10),4,6,8-tetraen-12-one

C20H24N2O2 (324.18376839999996)


   

5,8-dihydroxy-5,8-dimethyl-3-methylidene-2-oxo-octahydroazuleno[6,5-b]furan-7-yl acetate

5,8-dihydroxy-5,8-dimethyl-3-methylidene-2-oxo-octahydroazuleno[6,5-b]furan-7-yl acetate

C17H24O6 (324.1572804)


   

(3ar,4r,4as,5r,7r,7ar,8r,9as)-5,7-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate

(3ar,4r,4as,5r,7r,7ar,8r,9as)-5,7-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

ethyl 2-[7-hydroxy-5-(hydroxymethyl)-1,5-dimethyl-9-oxo-10-oxatricyclo[4.4.0.0²,⁴]decan-8-ylidene]propanoate

ethyl 2-[7-hydroxy-5-(hydroxymethyl)-1,5-dimethyl-9-oxo-10-oxatricyclo[4.4.0.0²,⁴]decan-8-ylidene]propanoate

C17H24O6 (324.1572804)


   

5,7-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate

5,7-dihydroxy-4a,8-dimethyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

(1r,5r,5as,9as,9bs)-1,9b-dihydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate

(1r,5r,5as,9as,9bs)-1,9b-dihydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate

C17H24O6 (324.1572804)


   

4-hydroxy-9,18,18-trimethyl-8-oxapentacyclo[10.5.1.0¹,¹³.0²,⁷.0⁹,¹³]octadeca-2,4,6,16-tetraene-16-carbaldehyde

4-hydroxy-9,18,18-trimethyl-8-oxapentacyclo[10.5.1.0¹,¹³.0²,⁷.0⁹,¹³]octadeca-2,4,6,16-tetraene-16-carbaldehyde

C21H24O3 (324.1725354)


   

(1's,3s,3's,6's,9'e,10'r)-9'-ethylidene-10'-(hydroxymethyl)-1-methyl-7'-azaspiro[indole-3,4'-tricyclo[4.3.1.0³,⁷]decan]-2-one

(1's,3s,3's,6's,9'e,10'r)-9'-ethylidene-10'-(hydroxymethyl)-1-methyl-7'-azaspiro[indole-3,4'-tricyclo[4.3.1.0³,⁷]decan]-2-one

C20H24N2O2 (324.18376839999996)


   

(1s,9s,12s,13s)-4-hydroxy-9,18,18-trimethyl-8-oxapentacyclo[10.5.1.0¹,¹³.0²,⁷.0⁹,¹³]octadeca-2,4,6,16-tetraene-16-carbaldehyde

(1s,9s,12s,13s)-4-hydroxy-9,18,18-trimethyl-8-oxapentacyclo[10.5.1.0¹,¹³.0²,⁷.0⁹,¹³]octadeca-2,4,6,16-tetraene-16-carbaldehyde

C21H24O3 (324.1725354)


   

5,13-dihydroxy-8-methoxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one

5,13-dihydroxy-8-methoxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one

C18H28O5 (324.1936638)


   

(3e,5r,6e,8s,13r,14r)-5,10-dihydroxy-8-methoxy-5,13,14-trimethyl-9-methylidene-1-oxacyclotetradeca-3,6-dien-2-one

(3e,5r,6e,8s,13r,14r)-5,10-dihydroxy-8-methoxy-5,13,14-trimethyl-9-methylidene-1-oxacyclotetradeca-3,6-dien-2-one

C18H28O5 (324.1936638)


   

6-{2-[(1r,2r,4s)-1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl]ethyl}naphthalene-1,4-dione

6-{2-[(1r,2r,4s)-1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl]ethyl}naphthalene-1,4-dione

C21H24O3 (324.1725354)


   

(3ar,4s,5ar,6r,9r,9as,9bs)-6,9-dihydroxy-5a,9-dimethyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl acetate

(3ar,4s,5ar,6r,9r,9as,9bs)-6,9-dihydroxy-5a,9-dimethyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl acetate

C17H24O6 (324.1572804)


   

(1r,5s,6s)-5-(acetyloxy)-3-(hydroxymethyl)-6-isopropyl-2-oxocyclohex-3-en-1-yl (2e)-2-methylbut-2-enoate

(1r,5s,6s)-5-(acetyloxy)-3-(hydroxymethyl)-6-isopropyl-2-oxocyclohex-3-en-1-yl (2e)-2-methylbut-2-enoate

C17H24O6 (324.1572804)


   

(3as,6s,6ar,9s,9as,9br)-6a-hydroxy-9a-(hydroxymethyl)-6-methyl-3-methylidene-2-oxo-octahydroazuleno[4,5-b]furan-9-yl acetate

(3as,6s,6ar,9s,9as,9br)-6a-hydroxy-9a-(hydroxymethyl)-6-methyl-3-methylidene-2-oxo-octahydroazuleno[4,5-b]furan-9-yl acetate

C17H24O6 (324.1572804)


   

4,4a-dimethyl-octahydronaphtho[4,4a-b]oxiren-5-yl 2-[(1-hydroxyethoxy)methyl]prop-2-enoate

4,4a-dimethyl-octahydronaphtho[4,4a-b]oxiren-5-yl 2-[(1-hydroxyethoxy)methyl]prop-2-enoate

C18H28O5 (324.1936638)


   

4-[(1e)-2-[3,5-dimethoxy-4-(3-methylbut-2-en-1-yl)phenyl]ethenyl]phenol

4-[(1e)-2-[3,5-dimethoxy-4-(3-methylbut-2-en-1-yl)phenyl]ethenyl]phenol

C21H24O3 (324.1725354)